Blue Lunula Related with Hydroxyurea
Journal Title: Turkish Journal of Hematology - Year 2013, Vol 30, Issue 1
Abstract
Hydroxyurea, which is an inhibitor of ribonucleoside reductase and is used as a systemic antitumor agent, is frequently used for the treatment of myeloproliferative and hematologic diseases. While the most common side effect is myelosuppression, gastrointestinal symptoms such as nausea,vomiting, stomatitis, and anorexia and rash, skin ulcers,hyperpigmentation in nails, and dermatologic toxicities like facial erythema may also be observed. At higher dosages,neurologic symptoms may be rarely seen (1,2).
Authors and Affiliations
Hava Teke, Abdülsamet Erden
Keywords
Related Articles
- EP ID EP105716
- DOI 10.4274/tjh.2011.0016
- Views 69
- Downloads 0
A Search for Beta Thalassemia Trait in India
To the Editor, The beta-thalassemia trait (BTT)—or beta-thalassemia minor—is a heterozygous condition in which only a single beta-globin gene is affected. The estimated prevalence of BTT in different regions of India is...
Oyun Çocuğunda, Geç Bulgu Veren Doğumsal Diyafram Hernisine Bağlı Ağır Demir Eksikliği Anemisi
Influence of Folate-Related Gene Polymorphisms on High-Dose Methotrexate-Related Toxicity and Prognosis in Turkish Children with Acute Lymphoblastic Leukemia
Objective: High-dose methotrexate (HD-MTX) is widely used in the consolidation phase of childhood acute lymphoblastic leukemia (ALL), but the roles that polymorphisms in folate-related genes (FRGs) play in HD-MTX toxicit...
Miyelodisplastik Sendrom, Psöriazis, Hipogamaglobulinemi ve Monozomi 7’si Olan Bir Çocuk Miyelodisplastik Sendrom Olgusu
1. Quiz in Hematology